Log in to save to my catalogue

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a75ea7e77a4d4edc993060b25acbbf6e

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid

About this item

Full title

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid

Publisher

London: Nature Publishing Group UK

Journal title

Nature communications, 2021-09, Vol.12 (1), p.5548-5548, Article 5548

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Isoniazid (INH) is a first-line anti-tuberculosis drug used for nearly 70 years. However, the mechanism underlying the side effects of INH has remained elusive. Here, we report that INH and its metabolites induce a post-translational modification (PTM) of histones, lysine isonicotinylation (K
inic
), also called 4-picolinylation, in cells and...

Alternative Titles

Full title

Isonicotinylation is a histone mark induced by the anti-tuberculosis first-line drug isoniazid

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_a75ea7e77a4d4edc993060b25acbbf6e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_a75ea7e77a4d4edc993060b25acbbf6e

Other Identifiers

ISSN

2041-1723

E-ISSN

2041-1723

DOI

10.1038/s41467-021-25867-y

How to access this item